Skip to main content
Equibles

STVN · Stevanato Group S.p.A. · Metrics

Track STVN — free

Use STVN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$20.48 -0.03 (-0.15%)
Rebalance outlook locked
Market Cap
$5.60B
Shares
273.13M

STVN metrics

59 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.51
Market cap
$5.60B

Price action

20 metrics
Price change (1W)
-2.5%
Price change (30D)
-0.3%
Price change (3M)
+11.1%
Price change (6M)
+33.1%
Price change (YTD)
+1.9%
Price change (1Y)
-11.0%
Trailing year
Price change (5Y)
-25.2%
52-week high
$27.61
52-week low
$13.43
Change from 52-week high
-25.7%
Change from 52-week low
+52.7%
Annualized volatility
48.0%
Annualized volatility (3M)
40.1%
Beta
1.2
RSI (14D)
45.1
Price vs SMA 50
+1.2%
Price vs SMA 200
+11.9%
Avg volume (3M)
394,214
Relative volume
0.5
Average dollar volume
$7.76M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
273.13M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
3.2
reciprocal yield 31.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.3%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.06
Dividend growth YoY
+0.0%
Dividend growth streak
1
Last ex-dividend
2026-06-11

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
29.0%
Operating margin
16.8%
Trailing 12 months
Net margin
11.8%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$4.91

Growth

11 metrics
Revenue growth YoY
+7.4%
Year over year
Net income growth YoY
+18.7%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+18.6%
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
+6.4%
Revenue CAGR (5Y)
+12.4%
EPS CAGR (3Y)
-1.9%
EPS CAGR (5Y)
+9.1%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-19.5%

Quality

14 metrics
Return on equity
9.4%
Return on assets
5.5%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$153.28M
Total assets
$2.99B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
126
13F filer change QoQ
-9
Institutional ownership
16.4%

Short interest

3 metrics
Short interest
0.4%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$268,346
Insider-sentiment score
34 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1849853 CUSIP T9224W109 13F (30d) 77 filings 77 filers Visit website Investor relations